Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-4561
Buddeberg, F; Beck-Schimmer, B; Spahn, D R (2008). Transfusion-transmissible infections and transfusion-related immunomodulation. Best Practice & Research: Clinical Anaesthesiology, 22(3):503-517.
View at publisher
The risk of acquiring a transfusion-transmitted infection has declined in recent years. However, after human immunodeficiency virus and hepatitis B and C virus transmission were successfully reduced, new pathogens are threatening the safety of the blood supply, especially in the face of rising numbers of immunocompromised transfusion recipients. Despite new standards in the manufacture and storage of blood products, bacterial contamination still remains a considerable cause of transfusion-related morbidity and mortality. Better allograft survival in kidney transplant patients and higher cancer recurrence rate in surgical oncology patients after allogeneic blood transfusions highlighted a previously underestimated side-effect: transfusion-related immunomodulation (TRIM). The precise pathomechanism still remains uncertain; however, its mostly deleterious effects--such as a higher incidence of postoperative or nosocomial infections--is increasingly accepted. Although transfusion-related immunomodulation is thought to be mediated mainly by donor white blood cells, the benefit of leukoreduction on overall mortality and on infectious complications is highly debatable.
90 downloads since deposited on 27 Oct 2008
10 downloads since 12 months
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Institute of Anesthesiology|
|DDC:||610 Medicine & health|
|Deposited On:||27 Oct 2008 08:27|
|Last Modified:||23 Nov 2012 15:14|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page